PREDICT Therapy Selection for JAK, T-cell, or IL-6 Inhibitor Therapies Using a Molecular Signature Response Classifier (PREDICT)
Clinical trial NCT06390709 · UNKNOWN
Trial details
- NCT number
- NCT06390709
- Sponsor
- Scipher Medicine
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2024-04-08
- Primary completion
- 2025-06-30
- Enrollment
- 1100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.